9-benzyl-8-[2-chloro-4-[2-(3,6-diazabicyclo[3.1.1]heptan-6-yl)ethoxy]phenyl]-6-(1-methylcyclopropyl)oxypurine
C29H31ClN6O2 — CID 171791399
Data last refreshed: (MolForge compound catalog, from PubChem)
About 9-benzyl-8-[2-chloro-4-[2-(3,6-diazabicyclo[3.1.1]heptan-6-yl)ethoxy]phenyl]-6-(1-methylcyclopropyl)oxypurine
9-benzyl-8-[2-chloro-4-[2-(3,6-diazabicyclo[3.1.1]heptan-6-yl)ethoxy]phenyl]-6-(1-methylcyclopropyl)oxypurine (PubChem CID 171791399) has the molecular formula C29H31ClN6O2 and a molecular weight of 531.06 g/mol. Its IUPAC name is 9-benzyl-8-[2-chloro-4-[2-(3,6-diazabicyclo[3.1.1]heptan-6-yl)ethoxy]phenyl]-6-(1-methylcyclopropyl)oxypurine.
Molecular Properties
| Compound Name | 9-benzyl-8-[2-chloro-4-[2-(3,6-diazabicyclo[3.1.1]heptan-6-yl)ethoxy]phenyl]-6-(1-methylcyclopropyl)oxypurine |
|---|---|
| PubChem CID | 171791399 |
| Molecular Formula | C29H31ClN6O2 |
| Molecular Weight | 531.06 g/mol |
| Exact Mass | 530.22 |
| IUPAC Name | 9-benzyl-8-[2-chloro-4-[2-(3,6-diazabicyclo[3.1.1]heptan-6-yl)ethoxy]phenyl]-6-(1-methylcyclopropyl)oxypurine |
| SMILES | CC1(Oc2ncnc3c2nc(-c2ccc(OCCN4C5CNCC4C5)cc2Cl)n3Cc2ccccc2)CC1 |
| InChI | InChI=1S/C29H31ClN6O2/c1-29(9-10-29)38-28-25-27(32-18-33-28)36(17-19-5-3-2-4-6-19)26(34-25)23-8-7-22(14-24(23)30)37-12-11-35-20-13-21(35)16-31-15-20/h2-8,14,18,20-21,31H,9-13,15-17H2,1H3 |
| InChIKey | MJJMLOHSYRCKOW-UHFFFAOYSA-N |
| XLogP | 4.55 |
| TPSA | 77.33 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 38 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 531.06 |
| LogP ≤ 5 | 4.55 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 171791399 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.